← Back to Intel
Insider ActivityDFTX
Karlin Daniel, Chief Medical Officer at Definium Therapeutics, Inc., sold $148K of DFTX
Updated Jun 12, 2026
Karlin Daniel
Chief Medical Officer
Definium Therapeutics, Inc. ·
$DFTX
Transaction Details
| Insider | Karlin Daniel |
|---|---|
| Title | Chief Medical Officer |
| Company | Definium Therapeutics, Inc. |
| Ticker | DFTX |
| Transaction Type | Sale |
| Transaction Date | 2026-03-25 |
| Shares Traded | 8,018 |
| Price Per Share | $18.47 |
| Total Value | $148K |
| Filed Date | 2026-03-26 |
| Accession Number | 0001193125-26-126830 |
Ownership Context
| Shares Owned After Transaction | 413,317 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001193125-26-126830
Other Insider Trades — DFTX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer | sold | $451K | 2026-03-25 |
| Sullivan Mark | Chief Legal Officer | sold | $198K | 2026-03-25 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for DFTX — Definium Therapeutics, Inc. →
Whisper Score — DFTX
50.0
Active Discussion
Current Whisper Score
Track DFTX insider activity in real time on The Wire →
Get alerts when Karlin Daniel files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 12, 2026 at 07:16 UTC